Archive: https://archive.today/V7GrW From the post: >>Millions of Americans who rely on medication to manage attention deficit hyperactivity disorder (ADHD) may be impacted by a new nationwide drug recall. Sun Pharmaceutical Industries has issued a voluntary recall of several lots of lisdexamfetamine dimesylate capsules, a generic version of an ADHD treatment prescribed for patients aged six and older. It is commonly known as Vyvanse and Arynta. The FDA classified the action as a Class II recall, meaning use of the product 'may cause temporary or medically reversible adverse health consequences,' though the risk of serious harm is considered remote.